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Prenatal dexamethasone (DEX) exposure triggers several 
changes in nervous, autonomic and immune systems later in 
adulthood. As a result, we have shown that prenatal 
administration of DEX is associated with an increase 
vulnerability to peptic disease in adult life. In this study, we 
aim to clarify the impact of DEX-induced deregulation in the 
secretion of pro- (IL-1and IL-6) and anti-inflamatory (IL-10) 
cytokines, as well as COX-1 and COX-2 in the gastric 
mucosa.  
Introduction 
Methods 
Results 
Rat dams were exposed to the synthetic glucocorticoid 
dexamethasone (1mg/Kg) on days 18 and 19 of gestation. 
COX-1, COX-2 and cytokine (IL-1β, IL-6 and IL-10) 
expression was assessed, by quantitative RT-PCR, in 
different regions of the stomach mucosa (fundus, body and 
antrum) of adult rats exposed to DEX (n=5) and CONT (n=5) 
in the prenatal period.  
IL-1β  profile in Gastric Mucosa 
 
Relative expression of mRNA obtained by RT-PCR 
in the gastric mucosa of prenatal DEX-treated 
animals. IL-1 pro-inflamatory cytokine show a 
high significantly expression level  in body 
region. P<0,05. 
 
Conclusion 
These observations, which identify glucocorticoid-sensitive gastric 
regions (antrum and body) in female progeny, pave way for future 
studies designed to understand how early life events can predispose 
individuals for developing peptic disease in adult life, and may 
contribute for the study of future therapeutic approaches to this 
pathology. 
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IL-1 Profile
Pro-inflamatory IL-6 Cytokine 
 
Interleukin IL-6 mRNA changes significantly 
(p<0,05) in DEX animals in antrum region.  
Interleukin-6 (IL-6) is proinflammatory 
cytokine that produces multifunctional 
effects. It is involved in the regulation of 
immune reactions, but it  has also been 
shown to be associated with tumor 
progression including inhibition of cancer 
cells apoptosis. 
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IL-6 Profile
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IL-10 Profile
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COX - 1 Profile
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COX-2 Profile
COX-2 (non-constitutive) isoform expression in Gastric 
Mucosa 
 
Effect of DEX-treated animals on mRNA expression of COX-2 . 
Total RNA was extracted from gastric mucosa.  
The results reveals that body gastric region is significantly 
sensitive (p<0,01) to COX-2 expression in DEX-treated animals.  
This may be implicated with pathophysiological reactions 
such inflammation. 
 
COX-1 (constitutive) isoform expression in Gastric Mucosa 
 
COX-1 is constitutively expressed in the gastrointestinal tract in 
large quantities and has been suggested to maintain mucosal 
integrity through continous generation of prostaglandins. Our  
observations reveals a significantly alterations on COX -1 
expression in DEX-treated rats (p<0,05) especially in body of 
gastric mucosa.   
Anti-inflamatory IL-10 Cytokine 
 
Anti-inflamatory cytokines play an important role in 
downregulation of inflammation and the prevention of 
neoplasic disorders. IL-10 are implicated in regulatory 
suppression of gastric inflammation. 
In this study we observed a high significantly IL-10 
expression in body of the stomach (p<0,05).  
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